Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting. [electronic resource]
Producer: 20160302Description: 214 p. digitalISSN:- 1479-5876
- Adult
- Aged
- Biopsy
- Cancer Vaccines -- immunology
- Cell Count
- Cyclophosphamide -- pharmacology
- Disease Progression
- Dose-Response Relationship, Immunologic
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- metabolism
- Humans
- Immunity -- drug effects
- Male
- Melanoma -- blood
- Middle Aged
- Monocytes -- drug effects
- Peptides -- immunology
- Radiography
- T-Lymphocytes, Regulatory -- drug effects
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.